Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 70 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
691 14.9 months Metastatic melanoma 4 Immunotherapy
Human Immune Therapy Center, University of Virginia United States 8/2013
Treatment Details: Patients: This phase 2 study involved metastatic melanoma patients who were divided into four separate treatment groups. Group A had 47 patients with a median age of 65 years; 56.1% were m
 
692 14.9 months Low-grade serous carcinoma of the ovary 3 Biologic therapy
University of Texas MD Anderson Cancer Center United States 6/2012
Treatment Details: Patients: This phase 2 study involved 13 patients with low-grade serous carcinoma (LGSC) of the ovary, peritoneum, or fallopian tube who had previously been treated with platinum- and taxan
 
693 14.9 months Newly diagnosed GBM Immunotherapy
Cedars-Sinai Medical Center United States 2/2001
Treatment Details: Patients: This Phase I study involved seven patients with glioblastoma multiforme, and two patients with anaplastic astrocytoma. Treatment: The treatment consisted of intradermal vaccinat
 
694 14.9 months Newly diagnosed GBM 4 Chemotherapy
Radiation
Seoul National University College of Medicine Korea 11/2002
Treatment Details: Patients: Thirty patients with newly diagnosed glioblastoma multiforme were enrolled in this Phase II study. Treatment: Treatment consisted of two chemotherapy drugs, ACNU and cisplatin (
 
695 14.9 months Newly diagnosed GBM Chemotherapy
Radiation
Surgery
Western Pennsylvania Cancer Institute United States 8/2002
Treatment Details: Patients: This study involved 270 patients (subjects in the “Valid Study Group”) divided into two groups. Group 1 contained 137 patients. Of these 137 patients, 123 had newly diagnosed gli
 
696 14.9 months Advanced NSCLC 5 Biologic therapy
Chemotherapy
Mount Sinai Cancer Center United States 2/2008
Treatment Details: Patients: This phase II trial involved 103 patients with advanced non-small-cell lung cancer. Treatment: Patients were treated with either erlotinib (a biological therapy) or paclitax
 
697 14.9 months Newly diagnosed GBM 4 Immunotherapy
Radiation
University of California San Francisco United States 1/2009
Treatment Details: Patients: This phase 2 study involved 30 patients with newly diagnosed glioblastoma. There were 14 men and 16 women. The median age was 53, ranging from 26 to 76 years. Treatment: Pat
 
698 14.9 months Advanced breast cancer 5 Chemotherapy
Edinburgh Cancer Research Center United Kingdom 8/2010
Treatment Details: Patients: This phase 3 study involved women with advanced breast cancer. Patients were separated into two treatment groups. Group A consisted of 207 women with a median age of 54 years an
 
699 14.8 months Recurrent or persistant ovarian or primary peritoneal cancer 4 Chemotherapy
University of Iowa Hospitals and Clinics United States 1/2010
Treatment Details: Patients: This phase 2 study involved 49 patients with recurrent or persistant ovarian or primary peritoneal cancer. These women’s cancer was also resistant to treatment with platinum and
 
700 14.8 months Advanced NSCLC 4 Biologic therapy
University of Texas Southwestern Medical Center United States 8/2009
Treatment Details: Patients: This phase 2 study involved 32 patients with advanced non-small-cell lung cancer. The median age was 66.5, ranging from 39 to 80 years of age. There were 19 men and 13 women in
 
Page 70 of 187  | Previous Page  | Next Page